Celadon Pharmaceuticals (LSE:CEL) Other Stockholders Equity : €8.93 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals Other Stockholders Equity?

Celadon Pharmaceuticals's Other Stockholders Equity for the quarter that ended in Dec. 2023 was €8.93 Mil.

Celadon Pharmaceuticals's quarterly Other Stockholders Equity increased from Dec. 2022 (€8.35 Mil) to Jun. 2023 (€8.95 Mil) but then declined from Jun. 2023 (€8.95 Mil) to Dec. 2023 (€8.93 Mil).

Celadon Pharmaceuticals's annual Other Stockholders Equity increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€8.35 Mil) and increased from Dec. 2022 (€8.35 Mil) to Dec. 2023 (€8.93 Mil).

Celadon Pharmaceuticals Other Stockholders Equity Historical Data

The historical data trend for Celadon Pharmaceuticals's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celadon Pharmaceuticals Other Stockholders Equity Chart

Celadon Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

8.35

8.93

Celadon Pharmaceuticals Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Stockholders Equity	Get a 7-Day Free Trial			-	7.14	8.35	8.95	8.93

Celadon Pharmaceuticals Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Celadon Pharmaceuticals Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Celadon Pharmaceuticals's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Celadon Pharmaceuticals (LSE:CEL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

32-33 Cowcross Street, London, GBR, EC1M 6DF

Website

https://www.celadonpharma.co.uk

Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis.

Celadon Pharmaceuticals (LSE:CEL) Headlines

No Headlines